Incannex Healthcare (IXHL) Projected to Post Quarterly Earnings on Monday

Incannex Healthcare (NASDAQ:IXHL) is projected to release its Q4 2025 results before the market opens on Monday, September 29th. Analysts expect the company to announce earnings of ($0.29) per share for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earningreport page for the latest details on the call scheduled for Friday, October 3, 2025 at 9:30 AM ET.

Incannex Healthcare Price Performance

Shares of IXHL opened at $0.52 on Monday. The stock has a market capitalization of $15.44 million, a PE ratio of -0.43 and a beta of 7.66. The business’s fifty day moving average price is $0.59 and its 200 day moving average price is $0.47. Incannex Healthcare has a 12-month low of $0.08 and a 12-month high of $3.12.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded shares of Incannex Healthcare to a “hold” rating in a research report on Friday, July 18th.

About Incannex Healthcare

Incannex Healthcare Inc, a clinical stage pharmaceutical development company, engages in the research, development, and sale of medicinal cannabinoid and psychedelic pharmaceutical products and therapies. It develops products for the treatment of obstructive sleep apnoea (OSA), traumatic brain injury (TBI) and concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, inflammatory bowel disease, anxiety disorders, addiction disorders, pain, and other indications.